Detalhe da pesquisa
1.
Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer.
Br J Cancer
; 128(10): 1850-1861, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36918717
2.
Single-cell immunophenotyping revealed the association of CD4+ central and CD4+ effector memory T cells linking exacerbating chronic obstructive pulmonary disease and NSCLC.
Front Immunol
; 14: 1297577, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38187374
3.
[Predictive relevance of KRAS mutational status in bone metastatic lung adenocarcinoma treated with bisphosphonate therapy]. / A KRAS-mutációs státusz prediktív szerepe biszfoszfonáttal kezelt, csontáttétet képzo tüdo-adenokarcinómában.
Magy Onkol
; 65(2): 103-111, 2021 Jun 03.
Artigo
em Húngaro
| MEDLINE | ID: mdl-34081758
4.
The effects of bisphosphonate and radiation therapy in bone-metastatic lung adenocarcinoma: the impact of KRAS mutation.
Transl Lung Cancer Res
; 10(2): 675-684, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33718013
5.
Feasibility study of in vitro drug sensitivity assay of advanced non-small cell lung adenocarcinomas.
BMJ Open Respir Res
; 7(1)2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32527872
6.
KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy.
Cancers (Basel)
; 11(10)2019 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31600989